An observational study in Cancer, sponsored by Canadian Cancer Trials Group. Recruiting at 16 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Canadian Cancer Trials Group · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.
It is anticipated that 1000 people will take part in this study. Participation in this study will only take about 10 minutes or less. Participants who choose to take part in this study will be asked to fill out a form with questions in English or French about the non-medical factors that influence health. This includes asking about the conditions and places in which the participant lives, learns, works, and plays. Participants will also be asked how they feel about answering these questions. Researchers will use this information to better understand who participates in clinical trials.
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 200 across 2,644 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Canadian Cancer Trials Group is the lead sponsor of 93 studies on the registry; 29 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 7 (88%) have results posted.
Counted across the registry records on this site, refreshed daily.
This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults (≥18 years) who are either:
Exclusion Criteria:
This study will use a standardized SDoH Questionnaire to collect the required sociodemographic data
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial
Time frame: 12 months
To assess the acceptability of this SDoH questionnaire to participants.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Jan 2027, 8 months after the start.
Of 1,099 non-industry observational studies under Neoplasms, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 227. This study's planned 8 months is below that.
Counting every sponsor, half of 1,247 studies reached it within 58 months; a quarter within 24 and three quarters within 210.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Canadian Cancer Trials Group